Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes

In this comprehensive program centered around live CCO Webinars at ASH 2020, experts discuss key developments in management of hemophilia A. Review their insights by reading focused clinical commentaries along with watching the on-demand Webcast and downloading slides from the symposium.
Guy A. Young, MD

ClinicalThought

Building from a solid foundation based on direct factor VIII replacement, management of hemophilia A now includes nonfactor therapies. Here’s my take on progress and future directions.

Guy A. Young, MD Released: October 14, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Genentech, a member of the Roche Group
Sanofi Genzyme Corporation
Takeda Pharmaceutical Company Ltd

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue